Across TCGA pan-cancer cohorts, LINC01912 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LINC01912’s most consistent transcriptional readouts.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where LINC01912 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01912 is over-expressed in tumor.
HNSC and LUSC are the cancer types where LINC01912 tumor–normal differential expression is most reproducible.